
Predictive Intelligence Meets Precision Biology
Prognosis AI + Omics
Web Co-Pilot
At Bayosthiti, we are pushing the boundaries of disease prediction with the Prognosis AI + Omics Web Co-Pilot – a two-stage artificial intelligence platform designed to analyse biological data and predict disease outcomes.
From oncology to cardiology, this platform empowers clinicians and researchers with a futuristic lens on patient prognosis and treatment planning.
Features
What is Prognosis AI + Omics Web Co-Pilot?
Prognosis AI automates bioinformatics today and maps disease paths and treatment tomorrow by transforming data into discovery.
OmicsWeb Copilot allows researchers to analyze complex RNA data using simple, natural language questions instead of complex code. For example, you could ask “Which genes are overexpressed in my treatment group compared to control?” and Copilot will perform the appropriate statistical analysis and visualization.

Key Features:

Two-stage
AI engine for outcome prediction

Predicts
relapse probabilities and disease trajectories

Works seamlessly
with Bayosthiti RNA-seq services

Web-based
interface for real-time interpretation

Built for
integration into clinical trial workflows

Exclusively
available to early adopters and collaborators

Real-World Impact
Transforming Cancer
Care and Beyond
Our platform successfully predicted relapse probabilities in Acute Myeloid Leukemia (AML), showcasing its clinical relevance and readiness for application across a wide spectrum of diseases.
our Collaborations
Current Clinical Collaborations in India
We are working with clinicians and researchers across India to deploy Prognosis AI in multiple ongoing trials using our RNA sequencing technology.
– Pan-Cancer (most major cancers in the Indian population)
– Coronary Artery Disease (CAD)
– Autoimmune Diseases
two-stage AI framework
How Does the Platform Work?
- Our two-stage AI framework integrates The result? Actionable insights delivered in a format that's accessible, adaptable, and clinically relevant.
- 01. Biological signal extraction from RNA-seq and other omics data
- 02. Predictive modelling using curated disease-specific datasets
Feature & Benefit
Why Choose Prognosis AI + Omics Web Co-Pilot?
- 01. Predictive accuracy Guides clinical decisions and trial outcomes
- 02. Disease versatility Oncology, cardiology, autoimmune disorders, and more
- 03. RNA-seq integration Unlocks full potential of transcriptomic data
- 04. Early adopter access Preferred integration with Bayosthiti’s AI pipeline suite
- 05. Scalable architecture Built for hospital, lab, and CRO use cases
Preferred Access for
Early Adopters
By joining us early, researchers and clinical collaborators gain priority access to our exclusive AI pipelines, especially when using Bayosthiti’s RNA sequencing services. It’s more than a tool; it’s a web-based co-pilot for clinical foresight.

how to collaborate
Accessing the Prognosis
AI Platform
Choose how you want to collaborate:
Option 1
→ Integrate with your existing RNA-seq or clinical trial workflows
→ Use our platform independently through Biostate.ai
Option 2
→ Collaborate on clinical studies
→ Leverage our AI as part of ongoing trials with Bayosthiti support
Get in Touch
Sales inquiries: sales@bayosthiti.ai
Technical support: asktech@bayosthiti.ai
More Info: Visit Biostate.ai to learn more

For Inquiries in India
- +91-7975311056
- Office Location: Center for Cellular and Molecular Platforms, C-CAMP GKVK Post, Bellary Rd, Bengaluru, Karnataka 560065
- partnerships@bayosthiti.ai